-

XIFIN Ranked #1 by Black Book Research for Laboratory RCM Services for Second Consecutive Year

Based on customer feedback in categories including strategic alignment, technology and security, XIFIN now recognized within Black Book rankings for five years running

SAN DIEGO--(BUSINESS WIRE)--XIFIN today announced it has been named the #1 vendor for Laboratory Support and Revenue Cycle Management (RCM) in the latest survey on healthcare outsourcing conducted by Black Book Research. This marks the fifth time the company has been included in Black Book’s rankings and the second consecutive time it has been awarded this specific accolade. XIFIN has more than 20 years’ experience partnering with hospital-based and independent laboratories, imaging centers, pathology practices, and other diagnostic providers to optimize billing and claims processing via its award-winning XIFIN RPM solution in a flexible, outsourced model.

The ongoing COVID-19 pandemic has resulted in labs nationwide facing fluctuations in routine and COVID test volumes. Many have made the shift towards digital operations in response to these complex testing demands and to help optimize operations despite volume surges as high as 250% of baseline, according to XIFIN’s Lab Volume Index. As such, 92% of hospital leaders have intensified their strategic planning efforts this year with many turning to technology innovations and services to complement existing operations, according to Black Book’s annual survey on healthcare outsourcing. With the hospital outsourcing market projected to reach $702 billion by 2027, hospital and healthcare leaders are more focused than ever on strategic priorities that implement digital technologies and work to improve patient access. Black Book’s report surveyed 1,570 laboratory physicians, clinicians, and specialists, as well as administrative, IT and finance leaders from practices, groups, clinics, and facilities to determine their satisfaction level, based on several functional areas.

“We’re proud to be recognized as the number one provider of outsourced lab support and RCM by our clients, particularly as the industry continues to stretch beyond its limits and move toward a hybrid model of supporting both routine and esoteric diagnostics alongside ongoing COVID-19 testing,” said Kyle Fetter, Chief Operating Officer at XIFIN. “Through continued collaboration with key decision makers and our deep expertise in the diagnostics market, we’re listening to clients’ needs, helping their organizations refocus priorities and enabling them to allocate their internal resources to where they’re most valuable.”

According to industry respondents, XIFIN took the top position for 10 of 18 pieces of criteria, including:

  • Strategic Alignment of Vendor Offerings to Provider Goals & Client’s Mission – Organizational structure meets stakeholder or customer needs, including MACRA, consumerism, RCM, and value-based care.
  • Best of Breed Technology and Process Improvement Developments – Vendor elevates customers through capabilities, equipment, technology, professional staff, and quality assurance initiatives, all delivered above expectations.
  • Data Security, Patient Privacy and Backup Services – Vendor provides highest level of security and back up services to provide secure and constantly dependable outsourced service offerings.

The company was also ranked #1 in areas like Client Relationships and Cultural Fit; Trust, Accountability, Transparency, Ethics; and Innovation and Optimization. In addition to these top ranks, XIFIN was among the top three vendors across all 18 criteria requirements, demonstrating the high value of the company’s continued technology innovation and commitment to providing quality services and support. The full Laboratory RCM Services report can be accessed here.

“Many hospitals and health systems have a cost structure in place that is not sustainable, and some organizations are making the decision to actually enhance clinical product lines by outsourcing to power up volumes and improve health consumer satisfaction,” said Doug Brown, President of Black Book Research. “Collaborating with a successful and reputable organization to outsource revenue cycle management is a valid strategy to achieve a financially healthier organization.”

Learn more about XIFIN’s comprehensive, award-winning RPM platform here, and its outsourced services offerings here.

About XIFIN

XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company's cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care. The company provides cross-specialty industry analytics including its Lab Volume Index which provides a measurement of laboratory testing volumes across the US. Its synthesis of diagnostic data enables comparisons of hospital, genetics, pathology, routine lab, COVID-19 and antibody testing across key segments. To learn more, visit www.XIFIN.com, follow XIFIN on Twitter and LinkedIn, or subscribe to the XIFIN blog.

Contacts

Julie Sculley
julie.sculley@fleishman.com
617-970-7876

XIFIN

Details
Headquarters: San Diego, CA
CEO: Lâle White
Employees: 900+
Organization: PRI

Release Summary
XIFIN named #1 vendor for Laboratory Support and Revenue Cycle Management in Black Book Research's survey on healthcare outsourcing.
Release Versions

Contacts

Julie Sculley
julie.sculley@fleishman.com
617-970-7876

More News From XIFIN

XiFin Announces Empower AI RCM Ecosystem to Redefine How Healthcare Revenue Operations Scale

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in revenue cycle management (RCM) solutions, today announced XiFin® Empower AI, an interoperable, intelligent AI RCM ecosystem designed to coordinate AI, automation, and agentic workflows across healthcare revenue operations. Built on XiFin’s industry-trusted encounter, financial, and payor data, XiFin Empower AI can deliver measurable improvements across the revenue cycle—including accelerated payment velocity, fewer manual touches, higher firs...

XiFin Reports Double-Digit Segment Growth and 21.1% Increase in Empower RCM Volume; Names New CTO to Accelerate AI Strategy

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM), today reported strong operational growth across key segments in 2025, including 16.4% growth in its molecular diagnostics segment and 13.3% growth in its hospital segment. Volume flowing through XiFin® Empower RCM increased 21.1%, reflecting accelerating adoption of the company’s next-generation AI-powered revenue cycle solution. Building on this momentum, XiFin also announced the appointment of Sanj...

XiFin Builds on Empower CareALERTS Success with New Capabilities for Pharmacy

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in revenue cycle management (RCM), including billing solutions enhanced with artificial intelligence (AI), today announced the expansion of its proven CareALERTS™ smart clinical messaging technology, with a pharmacy-focused offering that alerts pharmacists to patient-specific vaccination opportunities directly within their existing workflows. By delivering real-time immunization alerts at the point of care, CareALERTS for Pharmacy enables pharma...
Back to Newsroom